Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BD Blood coagulation factors
B02BD04 Coagulation factor IX
D08797 Freeze-dried human blood-coagulation factor IX <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Blood Component Deficiency/ Replacement
Blood Component Deficiency/ Replacement, Hemophilia B
Coagulation Factor IX (Recombinant)
D08797 Freeze-dried human blood-coagulation factor IX
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
634 Human blood preparations
6343 Plasma preparations
D08797 Freeze-dried human blood-coagulation factor IX
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG02013 Blood coagulation factor
DG00171 Blood coagulation factor IX
D08797 Freeze-dried human blood-coagulation factor IX
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
F9* [HSA_VAR:2158v1]
D08797 Freeze-dried human blood-coagulation factor IX <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08797
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG02013 Blood coagulation factor
DG00171 Blood coagulation factor IX